Neurology
Conference Coverage
Newest oral DMTs haven’t yet made a big impact in the MS world
“Now there are six oral DMTs competing among themselves for a relatively limited pool of patients.”
Conference Coverage
Most adult epilepsy-related deaths could be avoided
“The overall mortality is not reducing; people are dying young, and neurologists are really not getting involved.”
Conference Coverage
No benefit of three commonly used medications for MS fatigue
These findings will hopefully encourage doctors to “think twice before prescribing these medications that could be harmful and have no clear...
Conference Coverage
Nilotinib is safe in moderate and advanced Parkinson’s disease
Although the drug is safe and tolerable, it penetrates the brain poorly and does not change levels of dopamine or its metabolites.
Conference Coverage
Ofatumumab shows high elimination of disease activity in MS
The once-per-month self-injected therapy could offer an alternative to DMTs that require in-office infusion.
Conference Coverage
High levels of air pollution linked to increased MS risk
“Countermeasures that cut air pollution can be important for public health, not only to reduce deaths related to cardiac and pulmonary diseases...
Conference Coverage
Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease
One of two “identical studies” assessing a novel treatment in development for Alzheimer’s disease reports significant efficacy, while the other...
Conference Coverage
Galcanezumab looks promising for treatment-resistant migraine
The monoclonal antibody reduced the mean number of monthly migraine days in a 3-month open-label extension of the phase 3 CONQUER study.
Conference Coverage
COVID-19: Psychiatrists assess geriatric harm from social distancing
“Certainly the appalling number of deaths in nursing homes is the No. 1 horror of the pandemic.”
Conference Coverage
Social isolation tied to higher risk of cardiovascular events, death
“These results are especially important in the current times of social isolation during the coronavirus crisis.”
News
Framingham risk score may also predict cognitive decline
“In the absence of effective treatments for dementia, we need to monitor and control cardiovascular risk burden as a way to maintain patient’s...